Catherine Nyarady, a partner at Paul, Weiss, Rifkind, Wharton & Garrison, writes that there is little doubt that MedImmune will create a flurry of increased declaratory judgment actions challenging patents - including between parties who had seemingly resolved their disputes. How such actions are framed (contract versus patent) and the specific language of the license agreement are clearly important. However, the long-term impact of the MedImmune decision remains to be seen.
February 01, 2007 at 12:00 AM
1 minute read
Presented by BigVoodoo
This event shines a spotlight on the individuals, teams, projects and organizations that are changing the financial industry.
BTI provides leading tax professionals from financial institutions with unmatched tools and resources.
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
Our client, a small but highly sophisticated and entrepreneurial tax boutique in Charleston, SC, has asked for our firm s assistance in iden...
CORE RESPONSIBILITIES AND TASKS:(1) Tasks and responsibilities include:Reviewing and negotiating commercial agreements for internal business...
Boutique midtown Manhattan law firm specializing in sophisticated real estate litigation & representation of commercial and residential ...
